Details for New Drug Application (NDA): 085237
✉ Email this page to a colleague
NDA 085237 describes NATURAL ESTROGENIC SUBSTANCE-ESTRONE, which is a drug marketed by Watson Labs and is included in one NDA. Additional details are available on the NATURAL ESTROGENIC SUBSTANCE-ESTRONE profile page.
The generic ingredient in NATURAL ESTROGENIC SUBSTANCE-ESTRONE is estrone. There are nine drug master file entries for this compound. Additional details are available on the estrone profile page.
The generic ingredient in NATURAL ESTROGENIC SUBSTANCE-ESTRONE is estrone. There are nine drug master file entries for this compound. Additional details are available on the estrone profile page.
Summary for 085237
| Tradename: | NATURAL ESTROGENIC SUBSTANCE-ESTRONE |
| Applicant: | Watson Labs |
| Ingredient: | estrone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085237
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2MG/ML | ||||
| Approval Date: | Nov 23, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
